S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55

West Pharmaceutical Services Stock Forecast, Price & News

-7.44 (-1.96%)
(As of 01/18/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
401,248 shs
Average Volume
454,905 shs
Market Capitalization
$27.57 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

West Pharmaceutical Services logo

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.


See More Headlines

Industry, Sector and Symbol

Fabricated rubber products, not elsewhere classified
Health Care Supplies
Year Founded

Sales & Book Value

Annual Sales
$2.15 billion
Cash Flow
$6.21 per share
Book Value
$25.03 per share


Net Income
$346.20 million
Pretax Margin




Free Float
Market Cap
$27.57 billion

Company Calendar

Last Earnings
Ex-Dividend for 11/17 Dividend
Dividend Payable
Ex-Dividend for 2/2 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

2.57 out of 5 stars

Medical Sector

98th out of 1,414 stocks

Fabricated Rubber Products, Not Elsewhere Classified Industry

2nd out of 3 stocks

Analyst Opinion: 3.5Community Rank: 3.7Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

Is West Pharmaceutical Services a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" West Pharmaceutical Services stock.
View analyst ratings for West Pharmaceutical Services
or view top-rated stocks.

How has West Pharmaceutical Services' stock been impacted by COVID-19?

West Pharmaceutical Services' stock was trading at $147.83 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, WST stock has increased by 151.7% and is now trading at $372.16.
View which stocks have been most impacted by COVID-19

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for West Pharmaceutical Services

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) issued its quarterly earnings results on Thursday, October, 28th. The medical instruments supplier reported $2.06 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.80 by $0.26. The medical instruments supplier had revenue of $706.50 million for the quarter, compared to the consensus estimate of $687.09 million. West Pharmaceutical Services had a net margin of 22.85% and a trailing twelve-month return on equity of 30.35%. The firm's revenue was up 28.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.15 EPS.
View West Pharmaceutical Services' earnings history

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Wednesday, January 5th. Shareholders of record on Wednesday, January 19th will be given a dividend of $0.18 per share on Wednesday, February 2nd. This represents a $0.72 annualized dividend and a yield of 0.19%. The ex-dividend date of this dividend is Tuesday, January 18th.
View West Pharmaceutical Services' dividend history

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services pays an annual dividend of $0.72 per share and currently has a dividend yield of 0.19%. West Pharmaceutical Services has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of West Pharmaceutical Services is 8.93%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 7.99% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.
View West Pharmaceutical Services' dividend history.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY 2021 earnings guidance on Thursday, November, 4th. The company provided earnings per share guidance of $8.400-$8.500 for the period, compared to the Thomson Reuters consensus estimate of $8.210. The company issued revenue guidance of $2.80 billion-$2.81 billion, compared to the consensus revenue estimate of $2.80 billion.

What price target have analysts set for WST?

1 brokers have issued twelve-month price objectives for West Pharmaceutical Services' shares. Their forecasts range from $475.00 to $475.00. On average, they expect West Pharmaceutical Services' share price to reach $475.00 in the next year. This suggests a possible upside of 27.6% from the stock's current price.
View analysts' price targets for West Pharmaceutical Services
or view top-rated stocks among Wall Street analysts.

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the following people:
  • Eric Mark Green, President, Chief Executive Officer & Director
  • David A. Montecalvo, SVP, Chief Operations & Supply Chain Officer
  • Bernard J. Birkett, Chief Financial Officer, Treasurer & Senior VP
  • Silji Abraham, Chief Technology Officer & Senior Vice President
  • Annette F. Favorite, Chief Human Resources Officer & Senior VP

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services CEO Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among West Pharmaceutical Services' employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Intermede Investment Partners Ltd (0.31%), State of Alaska Department of Revenue (0.04%), Apella Capital LLC (0.02%), DNB Asset Management AS (0.02%), IFM Investors Pty Ltd (0.01%) and Crossmark Global Holdings Inc. (0.01%). Company insiders that own West Pharmaceutical Services stock include Annette F Favorite, David A Montecalvo, George Lloyd Miller, Patrick J Zenner, Quintin J Lai and Silji Abraham.
View institutional ownership trends for West Pharmaceutical Services

Which major investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Crossmark Global Holdings Inc., Strategy Asset Managers LLC, Stratos Wealth Partners LTD., Kovack Advisors Inc., DNB Asset Management AS, Koshinski Asset Management Inc., and IFM Investors Pty Ltd. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Quintin J Lai, and Silji Abraham.
View insider buying and selling activity for West Pharmaceutical Services
or view top insider-selling stocks.

Which major investors are buying West Pharmaceutical Services stock?

WST stock was acquired by a variety of institutional investors in the last quarter, including Brookstone Capital Management, Intermede Investment Partners Ltd, First Hawaiian Bank, IVC Wealth Advisors LLC, IMPACTfolio LLC, Wedmont Private Capital, CAPROCK Group Inc., and Exchange Traded Concepts LLC.
View insider buying and selling activity for West Pharmaceutical Services
or or view top insider-buying stocks.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $372.16.

How much money does West Pharmaceutical Services make?

West Pharmaceutical Services has a market capitalization of $27.57 billion and generates $2.15 billion in revenue each year. The medical instruments supplier earns $346.20 million in net income (profit) each year or $8.06 on an earnings per share basis.

How many employees does West Pharmaceutical Services have?

West Pharmaceutical Services employs 9,200 workers across the globe.

Does West Pharmaceutical Services have any subsidiaries?

The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..

When was West Pharmaceutical Services founded?

West Pharmaceutical Services was founded in 1923.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is www.westpharma.com.

Where are West Pharmaceutical Services' headquarters?

West Pharmaceutical Services is headquartered at 530 HERMAN O. WEST DRIVE, EXTON PA, 19341.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at (610) 594-2900, via email at [email protected], or via fax at 800-345-9800.

This page was last updated on 1/19/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.